Inhibition of platelet aggregation (Update 2023)

被引：0

作者：

Wascher, Thomas C. M. ^{[1
]}

Stulnig, Thomas M. H. ^{[2
,3
]}

Saely, Christoph H. ^{[4
,5
]}

Stechemesser, Lars ^{[6
]}

机构：

[1] Hanuschkrankenhaus, Med Abt 1, Vienna, Austria

[2] Klin Hietzing, Med Abt 3, Vienna, Austria

[3] Klin Hietzing, Karl Landsteiner Inst Stoffwechselerkrankungen & N, Vienna, Austria

[4] VIVIT Inst, Abt Innere Med 1, Akadem Lehrkrankenhaus Feldkirch, Feldkirch, Austria

[5] Private Univ Furstentum Liechtenstein, Triesen, Liechtenstein

[6] Paracelsus Med Privatuniv, Univ Klin Innere Med 1, Mullner Hauptstr 48, A-5020 Salzburg, Austria

来源：

WIENER KLINISCHE WOCHENSCHRIFT | 2023年 / 135卷 / SUPPL 1期

关键词：

Platelets anti platelet drugs; Acute atherothrombosis; Diabetes mellitus; COLLABORATIVE METAANALYSIS; PRIMARY PREVENTION; ASPIRIN; EVENTS;

D O I：

10.1007/s00508-023-02168-6

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Acute thrombotic complications as a key feature of accelerated atherothrombotic disease typically precipitate cardiovascular events and therefore strongly contribute to cardiovascular morbidity and mortality in patients with diabetes. Inhibition of platelet aggregation can reduce the risk for acute atherothrombosis. The present article represents the recommendations of the Austrian Diabetes Association for the use of antiplatelet drugs in patients with diabetes according to current scientific evidence.

引用

页码：161 / 163

页数：3

共 50 条

[31] Extract from Aronia melanocarpa fruits potentiates the inhibition of platelet aggregation in the presence of endothelial cells
Luzak, Boguslawa
Golanski, Jacek
Rozalski, Marek
Krajewska, Urszula
Olas, Beata
Watala, Cezary
ARCHIVES OF MEDICAL SCIENCE, 2010, 6 (02) : 141 - 144
[32] Oral platelet aggregation inhibitors
Sibbing, D.
Massberg, S.
KARDIOLOGE, 2012, 6 (05): : 399 - 411
[33] Lessons from platelet inhibition and patient outcomes
Held, Claes
CURRENT OPINION IN CARDIOLOGY, 2012, 27 (04) : 355 - 360
[34] Effects of ibuprofen on the magnitude and duration of aspirin's inhibition of platelet aggregation: Clinical consequences in stroke prophylaxis
Gengo, Francis M.
Rubin, Lisa
Robson, Matthew
Rainka, Michelle
Gengo, Michael E.
Mager, Donald E.
Bates, Vernice
JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 48 (01) : 117 - 122
[35] Population Pharmacodynamic Modelling of Aspirin- and Ibuprofen-Induced Inhibition of Platelet Aggregation in Healthy Subjects
Ying Hong
Fran M. Gengo
Michelle M. Rainka
Vernice E. Bates
Donald E. Mager
Clinical Pharmacokinetics, 2008, 47 : 129 - 137
[36] Platelet aggregation response to cyclooxygenase inhibition and thromboxane receptor antagonism using impedance aggregometry: A pilot study
Williams, Auni C.
Fisher, Kat G.
Alexander, Lacy M.
Kenney, W. Larry
PHYSIOLOGICAL REPORTS, 2024, 12 (16):
[37] Aspirin is insufficient in inhibition of platelet aggregation and thromboxane formation early after coronary artery bypass surgery
Bednar, Frantisek
Osmancik, Pavel
Hlavicka, Jan
Jedlickova, Vera
Paluch, Zoltan
Vanek, Tomas
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2009, 27 (04) : 394 - 399
[38] EFFECT OF PLASMA-FIBRINOGEN CONCENTRATION ON THE INHIBITION OF PLATELET-AGGREGATION AFTER TICLOPIDINE COMPARED WITH ASPIRIN
TOHGI, H
TAKAHASHI, H
KASHIWAYA, M
WATANABE, K
STROKE, 1994, 25 (10) : 2017 - 2021
[39] Aspirin is insufficient in inhibition of platelet aggregation and thromboxane formation early after coronary artery bypass surgery
Frantisek Bednar
Pavel Osmancik
Jan Hlavicka
Vera Jedlickova
Zoltan Paluch
Tomas Vanek
Journal of Thrombosis and Thrombolysis, 2009, 27 : 394 - 399
[40] Effect of mono-guanidine-like derivatives on platelet aggregation and tumour cell induced platelet aggregation
Hante, Nadhim Kamil
Keogh, Aaron P.
Huang, Yanni
Kapoor, Tanya
Bennett-Lenane, Harriet
Walsh, Eleanor
Rozas, Isabel
Medina, Carlos
Santos-Martinez, Maria Jose
RSC MEDICINAL CHEMISTRY, 2025, : 1695 - 1704

← 1 2 3 4 5 →